Metal chaperones prevent zinc-mediated cognitive decline
Paul A Adlard1, Jacqui Parncutt2, Varsha Lal2
1The Florey Institute for Neuroscience and Mental Health and The University of Melbourne, Parkville, Victoria 3052, Australia.
Metal chaperones like clioquinol can prevent age-related cognitive decline by restoring synaptic zinc levels and protein expression in the brain. This research highlights their potential for treating cognitive impairment in aging and Alzheimer's disease.
Area of Science:
- Neuroscience
- Biochemistry
- Pharmacology
Background:
- Zinc transporter-3 (ZnT3) protein regulates synaptic zinc, crucial for learning and memory.
- ZnT3 levels decrease with age and in Alzheimer's disease (AD), contributing to cognitive decline.
- Metal chaperones are being investigated for their therapeutic potential in neurological disorders.
Purpose of the Study:
- To investigate the efficacy of metal chaperones in preventing age-dependent cognitive decline.
- To explore the mechanisms by which metal chaperones restore synaptic function and protein expression.
- To determine if clioquinol increases synaptic zinc content in the hippocampus.
Main Methods:
- Utilized ZnT3 knockout (KO) mouse models for behavioral and electrophysiological analyses.
- Administered clioquinol (30 mg/kg/day for 6 weeks) to assess its effects on cognitive function.
- Analyzed pre- and postsynaptic protein levels (e.g., PSD-95, AMPAR, NMDAR2b) and hippocampal zinc content using synchrotron X-ray fluorescence microscopy.
Main Results:
- Clioquinol treatment prevented age-dependent cognitive deficits in ZnT3 KO mice.
- Clioquinol significantly restored levels of critical pre- and postsynaptic proteins.
- A small increase in hippocampal zinc content was observed, suggesting a role in synaptic restoration.
Conclusions:
- Metal chaperones, such as clioquinol, are effective in preventing cognitive decline associated with aging and AD.
- Restoration of synaptic protein expression and zinc homeostasis are key mechanisms underlying the therapeutic effects.
- Further research is needed to elucidate the precise role of hippocampal sub-regions in clioquinol's effects on synaptic plasticity.
Related Concept Videos
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
Role of Neurotransmitters in Memory
Glutamate and Synaptic Plasticity
Glutamate, the brain's main excitatory neurotransmitter, is...
Alzheimer's Disease: Treatment
Ligand-Gated Ion Channel Receptor: Gating Mechanism
Long-term Depression
Calcium Ion Concentration Mechanism
If over...
Alzheimer's Disease: Overview
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...


